Clinical Trial Update: The Selective Personalized Radio-Immunotherapy for Locally Advanced NSCLC Trial [Phase 2]

View source ↗

Summary

A Phase 2 trial update reports completion and results posting for the selective personalized radio-immunotherapy approach in locally advanced non-small cell lun…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Montefiore Medical Center | Conditions: Non-small Cell Lung Cancer, NSCLC | Phase 2 | Status: COMPLETED | Results posted: 2024-12-03